Biocon

Biocons Biosimilar products list Insulin Glargine (Basalog) & Disposable Pen (BASALOG One), TRASTUZUMAB, PEGFILGRASTIM & BEVACIZUMAB

The Branded Formulations portfolio includes products for chronic therapy areas: diabetes, cancer, nephrology, and immunology.

Generic Formulations, API's (Cardiology, Anti-Diabetics, Immunosuppressants, Multiple Sclerosis, Anti-Cancer) & Other Key Products list.

The company focuses on diabetes, oncology, and immunology and provides affordable, life-saving solutions.

It’s a chance at Biocon to work alongside some of the brightest minds in research, healthcare, pharmaceutical, biotechnology & business sector

The company is committed to diversity and inclusion and says diverse experiences and perspectives contribute to its culture.

The company offers opportunities across functions for individuals seeking career development and impact.

Fuelling lasting success through constant learning & development. It aligns individual success with organisation’s current & future growth

The company has a diverse, multidisciplinary group of knowledgeable and experienced professionals that provides expertise and guidance.

Biocon's key management team focuses on work practices and greater process maturity across the organisation.

A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases

Over four decades company milestones, business & parternships accomplishments, research & development achievements has built a strong legacy

The company aims to give patients worldwide access to affordable healthcare and alter the healthcare paradigm.

The company is committed to providing everyone, everywhere, affordable access to a portfolio of medicines for diabetes, oncology, and immunology.

Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs